文献速递儿科影像妇产影像US

先天性心脏缺陷和/或心律失常胎儿的血浆利钠肽水平

Plasma natriuretic peptide levels in fetuses with congenital heart defect and/or arrhythmia.
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-10-08

这项前瞻性观察研究纳入129例先天性心脏缺陷(CHD)和/或心律失常单胎与127例对照,比较出生时脐带血浆利钠肽水平与超声心动图提示胎儿心力衰竭的指标。CHD和/或心律失常胎儿利钠肽水平高于对照(P < 0.01),且与心血管轮廓(CVP)评分呈负相关(趋势P < 0.01);CVP评分≥ 8的CHD和/或心律失常胎儿与对照间利钠肽水平无差异。

要点

  • CHD和/或心律失常胎儿脐带血浆利钠肽水平高于对照(P < 0.01),且随CVP评分降低而升高(趋势P < 0.01)。
  • CVP评分≥ 8的CHD和/或心律失常胎儿利钠肽水平与对照无差异。
  • CVP评分≤ 7时,心动过速或心动过缓胎儿异常静脉多普勒表现更多更重且利钠肽水平高于CHD胎儿(P = 0.01)。

核心结论

  • CHD和/或心律失常胎儿的血浆利钠肽水平与胎儿心力衰竭严重程度相关;利钠肽升高主要归因于心律失常或CHD所致房室瓣反流引起的中静脉压升高,而非形态学异常本身。

研究设计与样本

  • 前瞻性观察研究,2012至2015年在三级儿科心脏中心开展,纳入129例CHD和/或心律失常单胎及127例对照,比较出生时脐带血浆心房利钠肽、脑利钠肽和N末端脑利钠肽前体水平与提示胎儿心力衰竭的超声表现(CVP评分及形态学特征)。

关键影像表现/征象

  • CHD和/或心律失常胎儿脐带血浆利钠肽水平高于对照(P < 0.01)。
  • CHD和/或心律失常胎儿利钠肽水平与CVP评分呈负相关(趋势P < 0.01)。
  • CVP评分≥ 8的CHD和/或心律失常胎儿与对照间利钠肽水平无差异。
  • CVP评分≤ 7时,心动过速或心动过缓胎儿异常静脉多普勒表现显著更多且更重,利钠肽水平高于CHD胎儿(P = 0.01)。
  • 右心缺陷伴中重度三尖瓣反流胎儿利钠肽水平显著高于其他类型CHD胎儿(P < 0.01)。

诊断标准与关键数值

  • 多因素分析显示CVP评分≤ 5、出生时心动过速或心动过缓、早产及脐动脉pH < 7.15与高利钠肽水平独立相关(P < 0.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Diagnosing fetal heart failure remains challenging because it is difficult to know how well the fetal myocardium will perform as loading conditions change. In adult cardiology, natriuretic peptides (NPs) are established markers of heart failure. However, the number of studies investigating NP levels in fetuses is quite limited. The aim of this study was to evaluate the significance of plasma NP levels in the assessment of heart failure in fetuses with a congenital heart defect (CHD) and/or arrhythmia.

METHODS: This was a prospective observational study conducted at a tertiary pediatric cardiac center. A total of 129 singletons with CHD and/or arrhythmia and 127 controls were analyzed between 2012 and 2015. Umbilical cord plasma atrial NP, brain NP and N-terminal pro-brain NP levels at birth were compared with ultrasonography findings indicating fetal heart failure, such as cardiovascular profile (CVP) score and morphological characteristics.

RESULTS: Fetuses with CHD and/or arrhythmia had higher NP levels than did controls (P < 0.01). NP levels of fetuses with CHD and/or arrhythmia were correlated inversely with CVP score (P for trend < 0.01). No differences in NP levels were found in fetuses with CHD and/or arrhythmia and a CVP score of ≥ 8 in comparison to controls. Multivariate analysis showed that a CVP score of ≤ 5, tachy- or bradyarrhythmia at birth, preterm birth and umbilical artery pH < 7.15 were associated independently with high NP levels (P < 0.01). Among fetuses with a CVP score of ≤ 7, abnormal venous Doppler sonography findings were significantly more common and more severe in fetuses with tachy- or bradyarrhythmia than in those with CHD, and those with tachy- or bradyarrhythmia had higher NP levels than did those with CHD (P = 0.01). Fetuses with right-heart defect and moderate or severe tricuspid valve regurgitation had significantly higher NP levels than did fetuses with other types of CHD (P < 0.01).

CONCLUSIONS: Plasma NP levels in fetuses with CHD and/or arrhythmia are correlated with the severity of fetal heart failure. Elevated NP levels are attributed mainly to an increase in central venous pressure secondary to arrhythmia or atrioventricular valve regurgitation due to CHD, rather than to the morphological abnormality itself. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Miyoshi T, Umekawa T, Hosoda H, et al. Plasma natriuretic peptide levels in fetuses with congenital heart defect and/or arrhythmia. Ultrasound Obstet Gynecol. 2018. PMID: 29024133. doi:10.1002/uog.18925

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。